Melatonin modulates permeability transition pore and 5-hydroxydecanoate induced K_ATP channel inhibition in isolated...

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Pharmacology

Background:

• Mitochondria are increasingly recognized for their role in neurodegenerative disorders, influencing cell death pathways.
• Melatonin (Mel) is known for its neuroprotective effects.
• The mitochondrial ATP-sensitive potassium (mtK_ATP) channel blocker 5-hydroxydecanoate (5-HD) and calcium (Ca²⁺) can induce alterations in the mitochondrial permeability transition pore (mPTP).

Purpose of the Study:

• To investigate the effects of 5-HD and Ca²⁺ on isolated brain mitochondria, and whether melatonin (Mel) and cyclosporin A (CsA) can counteract these effects.
• To explore the role of the mPTP in melatonin's and CsA's neuroprotective actions.

Main Methods:

• Isolated brain mitochondria were treated with Ca²⁺ and 5-HD.
• Mitochondrial swelling, membrane potential (Δψ_m), reactive oxygen species (ROS) production, and mitochondrial respiration were measured.
• The effects of Mel and CsA on these parameters were evaluated.

Main Results:

• Ca²⁺ and 5-HD induced mitochondrial swelling, decreased Δψ_m, depleted ROS, and inhibited mitochondrial respiration, indicating mPTP opening and mitochondrial dysfunction.
• Mel and CsA significantly restored mitochondrial swelling, Δψ_m, ROS levels, and respiration.
• These findings suggest Mel and CsA modulate mPTP opening, mitigating 5-HD and Ca²⁺-induced mitochondrial damage.

Conclusions:

• Melatonin and cyclosporin A protect brain mitochondria against dysfunction induced by 5-HD and Ca²⁺, likely by inhibiting mPTP opening.
• Inhibition of the mPTP is a potential mechanism underlying the neuroprotective effects of CsA and possibly Mel.
• Targeting the mPTP with agents like Mel represents a promising therapeutic strategy for neurodegenerative diseases.